CGH
STE icon

Crossmark Global Holdings’s Steris STE Stock Holding History

Crossmark Global Holdings’s Portfolio STE Stock Details STE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.36M Buy
6,445
+1,881
+41% +$403K 0.02% 556
2026
Q1 		$1.01M Sell
4,564
-2
-0% -$489 0.01% 599
2025
Q4 		$1.16M Buy
4,566
+745
+19% +$187K 0.02% 563
2025
Q3 		$945K Sell
3,821
-449
-11% -$107K 0.01% 647
2025
Q2 		$1.03M Sell
4,270
-559
-12% -$130K 0.02% 602
2025
Q1 		$1.09M Sell
4,829
-28
-0.6% -$6.16K 0.02% 580
2024
Q4 		$998K Sell
4,857
-1,153
-19% -$253K 0.02% 588
2024
Q3 		$1.46M Sell
6,010
-227
-4% -$53.1K 0.03% 488
2024
Q2 		$1.37M Sell
6,237
-114
-2% -$24.8K 0.03% 495
2024
Q1 		$1.43M Buy
6,351
+3
+0% +$677 0.03% 507
2023
Q4 		$1.4M Sell
6,348
-180
-3% -$38.1K 0.03% 509
2023
Q3 		$1.49M Sell
6,528
-100
-2% -$22.6K 0.03% 465
2023
Q2 		$1.52M Sell
6,628
-773
-10% -$155K 0.03% 476
2023
Q1 		$1.42M Sell
7,401
-648
-8% -$125K 0.03% 498
2022
Q4 		$1.49M Buy
8,049
+440
+6% +$77.4K 0.04% 468
2022
Q3 		$1.27M Buy
7,609
+31
+0.4% +$6.31K 0.04% 489
2022
Q2 		$1.56M Buy
7,578
+500
+7% +$113K 0.04% 441
2022
Q1 		$1.71M Buy
7,078
+80
+1% +$18.5K 0.04% 469
2021
Q4 		$1.7M Sell
6,998
-51
-0.7% -$11.7K 0.04% 473
2021
Q3 		$1.44M Buy
7,049
+268
+4% +$57.3K 0.03% 494
2021
Q2 		$1.4M Sell
6,781
-61
-0.9% -$12.3K 0.03% 503
2021
Q1 		$1.3M Sell
6,842
-490
-7% -$90.9K 0.03% 507
2020
Q4 		$1.39M Sell
7,332
-900
-11% -$168K 0.04% 472
2020
Q3 		$1.45M Sell
8,232
-200
-2% -$32K 0.04% 434
2020
Q2 		$1.29M Buy
8,432
+451
+6% +$68.7K 0.04% 455
2020
Q1 		$1.12M Buy
7,981
+879
+12% +$131K 0.04% 436
2019
Q4 		$1.08M Sell
7,102
-1,728
-20% -$253K 0.03% 537
2019
Q3 		$1.28M Sell
8,830
-10
-0.1% -$1.49K 0.04% 481
2019
Q2 		$1.32M Sell
8,840
-570
-6% -$76.1K 0.04% 493
2019
Q1 		$1.21M Buy
9,410
+320
+4% +$37.7K 0.03% 506
2018
Q4 		$971K Buy
9,090
+410
+5% +$45.8K 0.03% 538
2018
Q3 		$993K Sell
8,680
-510
-6% -$57.7K 0.03% 611
2018
Q2 		$965K Buy
9,190
+490
+6% +$49.3K 0.03% 610
2018
Q1 		$812K Sell
8,700
-1,110
-11% -$101K 0.02% 679
2017
Q4 		$858K Buy
9,810
+630
+7% +$56.2K 0.02% 694
2017
Q3 		$812K Buy
+9,180
New +$778K 0.02% 694
2016
Q3 		$812K Buy
+9,180
New +$649K 0.02% 694

Other funds holding STE

FAM
Fenimore Asset Management Cobleskill, New York $4.83B AUM 9.09% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
CAM
Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return
AC
Addenda Capital Montreal, Quebec, Canada $3.68B AUM 32.88% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
PL
Perpetual Ltd Sydney, New South Wales, Australia $7B AUM 19.75% 1-Year Est. Return
CCM
Carderock Capital Management Chevy Chase, Maryland $456M AUM 31.89% 1-Year Est. Return
BG
BDF Gestion Paris, France $747M AUM 47.35% 1-Year Est. Return
MCG
McCollum Christoferson Group Amherst, New York $341M AUM 15.01% 1-Year Est. Return

Crossmark Global Holdings's STE Position: Q2 2026 in Review

Crossmark Global Holdings increased its Steris (STE) stake by 41% in Q2 2026, buying an estimated $403K and bringing the position to 6,445 shares worth $1.36M. The position accounts for 0.02% of the portfolio, ranked #556.

Crossmark Global Holdings first reported a position in STE in Q3 2016 and has held it in 37 quarters since. The position peaked at $1.71M in Q1 2022. 91 funds tracked by Wall St. Rank hold STE as of Q2 2026.

  • Crossmark Global Holdings held 6,445 shares of Steris worth $1.36M as of Q2 2026.
  • Crossmark Global Holdings bought 1,881 Steris shares in Q2 2026, an estimated $403K.
  • Steris made up 0.02% of Crossmark Global Holdings's portfolio in Q2 2026, its #556 holding.
  • Crossmark Global Holdings first reported a position in Steris in Q3 2016 and has held it in 37 quarters since.
  • Crossmark Global Holdings's Steris position peaked at $1.71M in Q1 2022.
  • 91 funds tracked by Wall St. Rank held Steris as of Q2 2026.

Based on Crossmark Global Holdings's 13F filing for Q2 2026, filed 16 Jul 2026.